The U.S. Food and Drug Administration’s approval of Viz.ai’s hypertrophic cardiomyopathy establishes a new category for cardiovascular machine learning-based notification software.
WHY IT MATTERS
Viz.ai, a disease detection and intelligent care coordination company, said in its announcement…
Source: Healthcareitnews.com and Read More
Qantas data breach could affect 6 million customers – Help Net Security
Summarize this content to a maximum of 60 words: Qantas data breach could affect 6 million customers Help Net Security
